跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,676 条关于
“idiopathic thrombocytopenic purpura”
全部
4,676
临床试验
4,063
药物
58
机构
5
资讯
550
去年
Thrombocytopenia Treatment Market Shows Promising Growth with Novel Therapies and Clinical Trials
去年
Rituxan Approved in Japan for Pediatric Chronic ITP
12个月前
Novartis Ianalumab Combination Shows 45% Improvement in ITP Disease Control in Phase III Trial
2个月前
Rituximab Market Poised for Sustained Growth Through 2034, Driven by Multi-Indication Use and Biosimilar Expansion
去年
Sobi to Present New Hematology Data at ASH 2024, Highlighting Advances in Rare Blood Disorders
2个月前
Grifols Doses First Patients in Two Phase 3 Trials to Expand Labels for Gamunex-C and Xembify
去年
Global Thrombocytopenia Clinical Trials Market Sees Significant Growth in 2025
去年
Takeda's Adzynma Becomes First UK-Approved Treatment for Rare Blood Clotting Disorder cTTP
去年
Rilzabrutinib Shows Promise in Phase 3 Trial for Immune Thrombocytopenia
10个月前
FDA Investigates Fatal Adverse Event Linked to Takeda's Adzynma Enzyme Replacement Therapy
第 1 页，共 55 页
上一页
下一页
